Tobacco Harm Reduction
For the past 30 years, Pinney Associates has worked on research and policies to minimize the death and disease associated with smoking conventional cigarettes. Almost half a million Americans die every year from cigarette smoking, making it the leading cause of preventable death in the US – and 28 million US adults still smoke cigarettes. Our efforts have included helping smokers gain greater access to nicotine replacement therapies by facilitating over-the-counter availability, as well as advocating for regulations and policies directed at minimizing risk for those using nicotine-containing products.
(Text continues below photo)
The harm from tobacco comes overwhelmingly from use of combustible products such as cigarettes, while use of nicotine products that do not burn (such as nicotine replacement therapy and nicotine vapor products) could dramatically reduce harm.
Since October 2019, Pinney Associates has been and continues to consult to Juul Labs on nicotine vapor products to advance tobacco harm reduction.
We believe our work with Juul Labs can help accelerate the market away from combustible tobacco products, so that people who smoke cigarettes who want or need to continue using nicotine have appealing alternatives that substantially lower their risk of harm.
In addition, as of October 2024, Pinney Associates consults to Philip Morris International solely on US regulatory pathways for non-combustible, non-tobacco, nicotine products.
We do not work on combustible tobacco products but only on products that have the promise of allowing people who smoke cigarettes to get nicotine without exposure to the harmful components in tobacco smoke.
References
https://www.cdc.gov/tobacco/about/index.html
https://archive.cdc.gov/www_cdc_gov/tobacco/sgr/50th-anniversary/index.htm
